PUBLISHER: The Business Research Company | PRODUCT CODE: 1428061
PUBLISHER: The Business Research Company | PRODUCT CODE: 1428061
Viral Gastroenteritis Global Market Report 2024
Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of the gastrointestinal tract. Common signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and fever.
The main types of drugs used in the treatment of viral gastroenteritis include antibiotics, antacids, laxatives, antimotility agents, and others. Antacids are medications that neutralize stomach acid to alleviate heartburn and indigestion. Diagnosis typically involves a physical examination and a rapid stool test, indicated by symptoms such as watery diarrhea, abdominal cramps, and pain. The various types of viruses associated with viral gastroenteritis include norovirus, rotavirus, astrovirus, and enteric adenovirus. These drugs and diagnostic procedures are utilized by various end-users, including hospitals, clinics, pharmaceutical companies, diagnostic centers, ambulatory care centers, and others.
The viral gastroenteritis market research report is one of a series of new reports from The Business Research Company that provides viral gastroenteritis market statistics, including viral gastroenteritis industry global market size, regional shares, competitors with a viral gastroenteritis market share, detailed viral gastroenteritis market segments, market trends, and opportunities, and any further data you may need to thrive in the viral gastroenteritis industry. This viral gastroenteritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral gastroenteritis market size has grown strongly in recent years. It will grow from $6.34 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The expansion observed in the historical period can be attributed to several factors, including the prevalence of viral infections, global hygiene practices, advancements in diagnostics, increased global travel and tourism, and the impact of climate and environmental factors.
The viral gastroenteritis market size is expected to see steady growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The anticipated growth in the forecast period for viral gastroenteritis can be attributed to factors such as global health preparedness, the impact of climate change, the adoption of a one health approach, the implementation of epidemiological surveillance systems, and increased education and public awareness. Key trends expected during the forecast period include advancements in vaccine development, the use of advanced diagnostics, the integration of telemedicine in diagnosis, collaborative research initiatives, the application of personalized medicine approaches, and the adoption of digital health solutions.
The projected increase in the prevalence of gastrointestinal disorders is set to drive the growth of the viral gastroenteritis market in the foreseeable future. Gastrointestinal (GI) disorders encompass diseases affecting any part of the gastrointestinal tract, and viral gastroenteritis drugs and diagnostic treatments play a crucial role in providing suitable medication for those afflicted with the condition. As per a survey report by Bodibio in October 2021, covering 73,076 adults across 33 countries, 40% of respondents reported having a functional gastrointestinal disorder, including variations such as functional dyspepsia, irritable bowel syndrome, and functional constipation. This underscores the escalating prevalence of gastrointestinal disorders and, consequently, the growth of the viral gastroenteritis market.
The growth of the viral gastroenteritis market is anticipated to be fueled by the increasing awareness surrounding hygiene and sanitation practices. Hygiene involves personal habits such as handwashing, waste disposal, and cleanliness, contributing to a clean environment, while sanitation pertains to ensuring safe waste disposal, water treatment, and maintaining hygienic surroundings. The emphasis on hygiene and sanitation plays a critical role in preventing the transmission of viruses causing gastroenteritis. These measures interrupt the fecal-oral route of transmission, reduce contamination, and contribute to overall community health. For instance, a survey conducted by Citron Hygiene in September 2022 revealed that, pre-pandemic, only 11% of individuals washed their hands for the recommended 18-20 seconds, but during the pandemic, this number increased to 25%. Moreover, 67% of respondents felt that the pandemic heightened their fear of germs and awareness of hygiene. Therefore, the growing awareness of hygiene and sanitation practices is a significant driver for the viral gastroenteritis market.
A prominent trend gaining momentum in the viral gastroenteritis market is product innovation. Major companies operating in this market are directing their efforts toward developing new products to fortify their market positions. For example, in November 2022, GlaxoSmithKline plc obtained approval from the US Food and Drug Administration (FDA) for an oral-dosing applicator-only presentation of ROTARIX, an oral vaccine to prevent rotavirus gastroenteritis in infants. This new presentation eliminates the need for reconstitution at the point of use, offering added convenience for healthcare providers. The approval is based on international clinical trial data demonstrating safety, tolerability, and immunogenicity compared to the lyophilized formulation.
Leading companies in the viral gastroenteritis market are introducing innovative products such as PCR kits for gastrointestinal infectious diseases to gain a competitive edge. PCR kits, also known as Polymerase Chain Reaction kits, are molecular biology tools designed for the amplification and detection of specific DNA sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd. launched 10 Real Time PCR Kits designed for the accurate detection of gastrointestinal pathogens. Covering a range of bacterial, viral, and parasitic pathogens associated with gastrointestinal infections, this solution provides a streamlined approach from sample pre-processing to PCR amplification analysis.
In March 2021, Hologic, Inc. acquired Diagenode for $159 million, a move aimed at expanding and diversifying its diagnostic business. Diagenode, a Belgium-based diagnostic assay manufacturer, offers a comprehensive array of real-time PCR tests for detecting bacteria, parasites, and viruses involved in various infections, including gastroenteritis. This strategic acquisition positions Hologic to broaden its diagnostic capabilities across customer segments, test menus, and geography.
Major companies operating in the viral gastroenteritis market report are Pfizer Inc., Abbvie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Daiichi Sankyo Company Limited, Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics PLC, Dr. Reddy's Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Ironwood Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan PLC, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited
North America was the largest region in the viral gastroenteritis market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viral gastroenteritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral gastroenteritis market consists of revenues earned by entities by providing various diagnostics such as polymerase chain reaction testing and immunoassays. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral gastroenteritis market also includes sales of antiemetics, and chemotherapy drugs used for treating viral gastroenteritis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Gastroenteritis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on viral gastroenteritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral gastroenteritis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The viral gastroenteritis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
- 1) By Drugs: Antibiotics; Antacids; Laxatives; Antimotility Agents; Others Drugs
- 2) By Diagnosis: Physical Examination; Rapid Stool Test
- 3) By Indication: Watery Diarrhea; Abdominal Cramps; Pain; Other Indications
- 4) By Type Of Virus: Norovirus; Rotavirus; Astrovirus; Enteric Adenovirus
- 5) By End User: Hospitals; Clinics; Pharmaceutical Companies; Diagnostic Centers; Ambulatory Care Centers; Others End Users
- Companies Mentioned: Pfizer Inc.; Abbvie Inc.; Bayer AG; Sanofi S.A.; AstraZeneca Plc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Viral Gastroenteritis Market Characteristics
3. Viral Gastroenteritis Market Trends And Strategies
4. Viral Gastroenteritis Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Viral Gastroenteritis Market Size and Growth
- 5.1. Global Viral Gastroenteritis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Viral Gastroenteritis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Viral Gastroenteritis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Viral Gastroenteritis Market Segmentation
- 6.1. Global Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Antibiotics
- Antacids
- Laxatives
- Antimotility Agents
- Others Drugs
- 6.2. Global Viral Gastroenteritis Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Physical Examination
- Rapid Stool Test
- 6.3. Global Viral Gastroenteritis Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Watery Diarrhea
- Vomiting
- Abdominal Cramps
- Pain
- Other Indications
- 6.4. Global Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Norovirus
- Rotavirus
- Astrovirus
- Enteric Adenovirus
- 6.5. Global Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals
- Clinics
- Pharmaceutical Companies
- Diagnostic Centers
- Ambulatory Care Centers
- Others End Users
7. Viral Gastroenteritis Market Regional And Country Analysis
- 7.1. Global Viral Gastroenteritis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Viral Gastroenteritis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Viral Gastroenteritis Market
- 8.1. Asia-Pacific Viral Gastroenteritis Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Viral Gastroenteritis Market
- 9.1. China Viral Gastroenteritis Market Overview
- 9.2. China Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Viral Gastroenteritis Market
- 10.1. India Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Viral Gastroenteritis Market
- 11.1. Japan Viral Gastroenteritis Market Overview
- 11.2. Japan Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Viral Gastroenteritis Market
- 12.1. Australia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Viral Gastroenteritis Market
- 13.1. Indonesia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Viral Gastroenteritis Market
- 14.1. South Korea Viral Gastroenteritis Market Overview
- 14.2. South Korea Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Viral Gastroenteritis Market
- 15.1. Western Europe Viral Gastroenteritis Market Overview
- 15.2. Western Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Viral Gastroenteritis Market
- 16.1. UK Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Viral Gastroenteritis Market
- 17.1. Germany Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Viral Gastroenteritis Market
- 18.1. France Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Viral Gastroenteritis Market
- 19.1. Italy Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Viral Gastroenteritis Market
- 20.1. Spain Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Viral Gastroenteritis Market
- 21.1. Eastern Europe Viral Gastroenteritis Market Overview
- 21.2. Eastern Europe Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Viral Gastroenteritis Market
- 22.1. Russia Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Viral Gastroenteritis Market
- 23.1. North America Viral Gastroenteritis Market Overview
- 23.2. North America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Viral Gastroenteritis Market
- 24.1. USA Viral Gastroenteritis Market Overview
- 24.2. USA Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Viral Gastroenteritis Market
- 25.1. Canada Viral Gastroenteritis Market Overview
- 25.2. Canada Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Viral Gastroenteritis Market
- 26.1. South America Viral Gastroenteritis Market Overview
- 26.2. South America Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Viral Gastroenteritis Market
- 27.1. Brazil Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Viral Gastroenteritis Market
- 28.1. Middle East Viral Gastroenteritis Market Overview
- 28.2. Middle East Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Viral Gastroenteritis Market
- 29.1. Africa Viral Gastroenteritis Market Overview
- 29.2. Africa Viral Gastroenteritis Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Viral Gastroenteritis Market, Segmentation By Type Of Virus, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Viral Gastroenteritis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Viral Gastroenteritis Market Competitive Landscape And Company Profiles
- 30.1. Viral Gastroenteritis Market Competitive Landscape
- 30.2. Viral Gastroenteritis Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. AbbVie Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. AstraZeneca Plc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc.
31. Viral Gastroenteritis Market Other Major And Innovative Companies
- 31.1. Abbott Laboratories
- 31.2. GlaxoSmithKline Plc.
- 31.3. Takeda Pharmaceutical Company Limited
- 31.4. Eli Lilly and Company
- 31.5. Amgen Inc.
- 31.6. C.H. Boehringer Sohn AG & Co. KG
- 31.7. Daiichi Sankyo Company Limited
- 31.8. Regeneron Pharmaceuticals Inc.
- 31.9. Mylan N.V.
- 31.10. Astellas Pharma Inc.
- 31.11. Fresenius Kabi AG
- 31.12. Bausch Health Companies Inc.
- 31.13. Alexion Pharmaceuticals Inc.
- 31.14. Horizon Therapeutics Plc
- 31.15. Dr. Reddy's Laboratories Ltd.
32. Global Viral Gastroenteritis Market Competitive Benchmarking
33. Global Viral Gastroenteritis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Viral Gastroenteritis Market
35. Viral Gastroenteritis Market Future Outlook and Potential Analysis
- 35.1 Viral Gastroenteritis Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Viral Gastroenteritis Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Viral Gastroenteritis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
